Clinical Trials Logo

Sarcomatoid Mesothelioma clinical trials

View clinical trials related to Sarcomatoid Mesothelioma.

Filter by:
  • Terminated  
  • Page 1

NCT ID: NCT01861301 Terminated - Clinical trials for Recurrent Malignant Mesothelioma

Tivantinib in Treating Patients With Previously Treated Malignant Mesothelioma

Start date: January 2013
Phase: Phase 2
Study type: Interventional

This phase II trial studies how well tivantinib works in treating patients with previously treated malignant mesothelioma. Tivantinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.